eamdacademy.org-vNCh-1792230029-c710578243 1792230029 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2026 5 1 George Papadopoulos Eleni Georgiou 2026 10.68159/c710578243 https://eamdacademy.org/pub/journal/3/article/c710578243 Gómez-Bombarelli R, Wei JN, Duvenaud D, Hernández-Lobato JM, Sánchez-Lengeling B, Sheberla D, et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci. 2018;4(2):268-76. Sanchez-Lengeling B, Aspuru-Guzik A. Inverse molecular design using machine learning: generative models for matter engineering. Science. 2018;361(6400):360-5. Popova M, Isayev O, Tropsha A. Deep reinforcement learning for de novo drug design. Sci Adv. 2018;4(7):eaap7885. Chen H, Engkvist O, Wang Y, Olivecrona M, Blaschke T. The rise of deep learning in drug discovery. Drug Discov Today. 2018;23(6):1241-50. Bannigan P, Aldeghi M, Bao Z, Häse F, Aspuru-Guzik A, Allen C. Machine learning directed drug formulation development. Adv Drug Deliv Rev. 2021;175:113806. Guidotti R, Monreale A, Ruggieri S, Turini F, Giannotti F, Pedreschi D. A survey of methods for explaining black box models. ACM Comput Surv. 2018;51(5):1-42. Arrieta AB, Díaz-Rodríguez N, Del Ser J, Bennetot A, Tabik S, Barbado A, et al. Explainable Artificial Intelligence (XAI): concepts, taxonomies, opportunities and challenges toward responsible AI. Inf Fusion. 2020;58:82-115. Benjamens S, Dhunnoo P, Meskó B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit Med. 2020;3(1):118. Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015–20): a comparative analysis. Lancet Digit Health. 2021;3(3):e195-203. Elbadawi M, Castro BM, Gavins FK, Ong JJ, Gaisford S, Pérez G, et al. M3DISEEN: a novel machine learning approach for predicting the 3D printability of medicines. Int J Pharm. 2020;590:119837. Narayanan H, Dingfelder F, Butté A, Lorenzen N, Sokolov M, Arosio P. Machine learning for biologics: opportunities for protein engineering, developability, and formulation. Trends Pharmacol Sci. 2021;42(3):151-65. Narayanan H, Dingfelder F, Condado Morales I, Patel B, Heding KE, Bjelke JR, et al. Design of biopharmaceutical formulations accelerated by machine learning. Mol Pharm. 2021;18(10):3843-53. Zulbeari N, Wang F, Mustafova SS, Parhizkar M, Holm R. Machine learning strengthened formulation design of pharmaceutical suspensions. Int J Pharm. 2025;668:124967. Li L, Back SI, Ma J, Guo Y, Galeandro-Diamant T, Clénet D. Bayesian optimization and machine learning for vaccine formulation development. PLoS One. 2025;20(6):e0324205. Markus AF, Kors JA, Rijnbeek PR. The role of explainability in creating trustworthy artificial intelligence for health care: a comprehensive survey of the terminology, design choices, and evaluation strategies. J Biomed Inform. 2021;113:103655. Terranova N, Renard D, Shahin MH, Menon S, Cao Y, Hop CE, et al. Artificial intelligence for quantitative modeling in drug discovery and development: an innovation and quality consortium perspective on use cases and best practices. Clin Pharmacol Ther. 2024;115(4):658-72. Jiménez-Luna J, Grisoni F, Schneider G. Drug discovery with explainable artificial intelligence. Nat Mach Intell. 2020;2(10):573-84. Polykovskiy D, Zhebrak A, Sanchez-Lengeling B, Golovanov S, Tatanov O, Belyaev S, et al. Molecular sets (MOSES): a benchmarking platform for molecular generation models. Front Pharmacol. 2020;11:565644. Ros H, Abdalla Y, Cook MT, Shorthouse D. Efficient discovery of new medicine formulations using a semi-self-driven robotic formulator. Digital Discovery. 2025;4(8):2263-72. Lavecchia A. Deep learning in drug discovery: opportunities, challenges and future prospects. Drug Discov Today. 2019;24(10):2017-32. Bao Z, Bufton J, Hickman RJ, Aspuru-Guzik A, Bannigan P, Allen C. Revolutionizing drug formulation development: the increasing impact of machine learning. Adv Drug Deliv Rev. 2023;202:115108. Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat Mach Intell. 2019;1(5):206-15. Gunning D, Aha DW. DARPA's explainable artificial intelligence program. AI Mag. 2019;40(2):44-58. Schneider G. Automating drug discovery. Nat Rev Drug Discov. 2018;17(2):97-113. Murray JD, Lange JJ, Bennett-Lenane H, Holm R, Kuentz M, O'Dwyer PJ, et al. Advancing algorithmic drug product development: recommendations for machine learning approaches in drug formulation. Eur J Pharm Sci. 2023;191:106562. Elton DC, Boukouvalas Z, Fuge MD, Chung PW. Deep learning for molecular design—a review of the state of the art. Mol Syst Des Eng. 2019;4(4):828-49. Vamathevan J, Clark D, Czodrowski P, Dunham I, Ferran E, Lee G, et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019;18(6):463-77. Huanbutta K, Burapapadh K, Kraisit P, Sriamornsak P, Ganokratanaa T, Suwanpitak K, et al. Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance. Eur J Pharm Sci. 2024;203:106938.